Cargando…
ChAdOx1 nCoV-19 vaccine for SARS-CoV-2 – Authors' reply
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier Ltd.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7832923/ https://www.ncbi.nlm.nih.gov/pubmed/33160565 http://dx.doi.org/10.1016/S0140-6736(20)32267-4 |
| _version_ | 1783641943673143296 |
|---|---|
| author | Voysey, Merryn Pollard, Andrew J |
| author_facet | Voysey, Merryn Pollard, Andrew J |
| author_sort | Voysey, Merryn |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7832923 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | Elsevier Ltd. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-78329232021-01-26 ChAdOx1 nCoV-19 vaccine for SARS-CoV-2 – Authors' reply Voysey, Merryn Pollard, Andrew J Lancet Correspondence Elsevier Ltd. 2020 2020-11-05 /pmc/articles/PMC7832923/ /pubmed/33160565 http://dx.doi.org/10.1016/S0140-6736(20)32267-4 Text en © 2020 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Correspondence Voysey, Merryn Pollard, Andrew J ChAdOx1 nCoV-19 vaccine for SARS-CoV-2 – Authors' reply |
| title | ChAdOx1 nCoV-19 vaccine for SARS-CoV-2 – Authors' reply |
| title_full | ChAdOx1 nCoV-19 vaccine for SARS-CoV-2 – Authors' reply |
| title_fullStr | ChAdOx1 nCoV-19 vaccine for SARS-CoV-2 – Authors' reply |
| title_full_unstemmed | ChAdOx1 nCoV-19 vaccine for SARS-CoV-2 – Authors' reply |
| title_short | ChAdOx1 nCoV-19 vaccine for SARS-CoV-2 – Authors' reply |
| title_sort | chadox1 ncov-19 vaccine for sars-cov-2 – authors' reply |
| topic | Correspondence |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7832923/ https://www.ncbi.nlm.nih.gov/pubmed/33160565 http://dx.doi.org/10.1016/S0140-6736(20)32267-4 |
| work_keys_str_mv | AT voyseymerryn chadox1ncov19vaccineforsarscov2authorsreply AT pollardandrewj chadox1ncov19vaccineforsarscov2authorsreply |